BioResearch Open Access Launching in March 2012 from Mary Ann Liebert, Inc., publishers

BioResearch Open Access, a new bimonthly peer-reviewed open access journal, will launch in March 2012 by Mary Ann Liebert, Inc., publishers (www.liebertpub.com).
 
Feb. 8, 2012 - PRLog -- New Rochelle, NY – BioResearch Open Access, a new bimonthly peer-reviewed open access journal, will launch in March 2012 by Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The Journal will provide a new rapid-publication forum for a broad range of scientific topics including but not limited to molecular and cellular biology, tissue engineering and biomaterials, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience.  Further information is available at http://www.liebertpub.com/biores.

The new Journal is under the leadership of Editor Jane Taylor, PhD, Senior Research Fellow, MRC Centre for Regenerative Medicine, University of Edinburgh, and seasoned journal editors as Section Editors, including James M. Wilson, MD, PhD, Gene Therapy Program, University of Pennsylvania; Antonios G. Mikos, PhD, BioScience Research Collaborative, Rice University, Houston, TX; Peter C. Johnson, MD, President and CEO, Scintellix, LLC, Raleigh, NC; Aubrey D.N.J. de Grey, PhD, SENS Foundation, Cambridge, UK; Alan J. Russell, PhD, Distinguished University Professor & Founding Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh & UPMC; Thomas Hope, PhD, Professor of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL;  Ganes C. Sen, PhD, Department of Molecular Genetics, Cleveland Clinic Foundation, Cleveland, OH ; Bruce A. Sullenger, PhD, Director, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, Graham C. Parker, PhD, Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI;  Carol Shoshkes Reiss, PhD, Department of Biology Center for Neural Science, New York University, New York, NY; Stephen C. Ekker, PhD, Department of Biochemistry and Molecular Biology, Rochester, MN; John B. West, MD, PhD, University of California, San Diego, La Jolla, CA; David L. Woodland, PhD, Chief Scientific Officer, Keystone Symposia on Molecular and Cellular Biology, Silverthorne, CO; and Stephen Higgs, PhD, FRES, Research Director, Biosecurity Research Institute, Kansas State University, Manhattan, KS.

The Journal will publish basic science and translational research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor.  All articles in BioResearch Open Access will be published online within 4 weeks of acceptance.  Articles will be fully open access and posted on PubMedCentral.  All articles submitted through May 15, 2012 will be made open access with no article processing charges. BioResearch Open Access is fully NIH-, HHMI- and Wellcome Trust compliant.
 
The Journal will be published both in print and online.  Full details about the Journal are available at http://www.liebertpub.com/biores.

BioResearch Open Access will be a fully refereed multidisciplinary journal,” says Mary Ann Liebert, president of Mary Ann Liebert, Inc. “Reviewers will be selected by highly authoritative Section Editors and papers will be accepted on the basis of those reviews to ensure the integrity of editorial content and provide the checks and balances that rigorous peer review ensures.  It is very gratifying that the scientific community is supportive of this fully open access publication and enthusiastic about participating.”

# # #

Mary Ann Liebert, Inc. (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Tissue Engineering, Human Gene Therapy, Nucleic Acid Therapeutics, Viral Immunology, DNA and Cell Biology, and Antioxidants and Redox Signaling. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available at http://www.liebertpub.com.
End
Mary Ann Liebert, Inc., publishers PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share